Le Lézard
Classified in: Health
Subjects: WOM, SBS

First Sports Supplement Formulated Specifically for Female Athletes and Their Hormonal Cycle


DENVER, Nov. 25, 2020 /PRNewswire/ -- For too long sport supplements have been designed for men. Even supplements marketed to women have not been developed for the specific needs of the female athlete. Prior to the Revitalization Act in 19931, only men were considered in sports medicine research.  Progress has slowly been made since the Act, with the regulated inclusion of women in clinical trials, but supplements are still developed through studies which test women exclusively during their low hormone phase - this avoids all effects women's hormones have on performance. Supplement brands have taken a shortcut to avoid the high costs and complicated research needed to study women throughout their full cycle. According to Venus225 Owner and Founder, Karen Oliver- "This is about to change! We are entering a new age for female athletes and their supplements!"

Venus225 is a female-owned and operated boutique company, specializing in sport supplements that focus on helping women become fitter and healthier. The Venus225 concept and products are based on research and development that emphasize the two main hormonal phases women experience every month. This approach to wellness is groundbreaking as it allows women to plan their training and recovery based on how their body functions and reacts to training in conjunction with their female hormones.

The first product Venus225 will release is a series of Electrolyte Powders, which have been developed for each of the two main hormonal phases of the female body through varying combinations of ingredients, which address the specific needs of each phase.  When women fail to address the range of needs their bodies have throughout their hormonal cycle, they are at high risk for issues such as poor sleep quality, low energy, anxiety, overtraining and adrenal fatigue, muscle mass loss, and athletic amenorrhea. This affects not only professional athletes but also active women and amateur athletes.

Venus225 products are designed to target women's specific needs at the appropriate times of the cycle, helping to balance out the ups and downs of hormones.

Venus225 has an avant-garde concept, as well as products, and is committed to providing educational information through social media and newsletters to help women become more cognizant of their needs. According to their founder, "Our goal is to be more than just another supplement, we want to leave a positive footprint by disrupting the way the world looks at women's training regimens, health and well-being.

Venus225 products are expected to hit the market by the end of 2020.

Karen Oliver and the Venus225 Team are available for interviews, 404-951-7055 / [email protected]  





1 S. Congress. National Institutes of Health Revitalization Act of 1993. Pub Law 1993: 103-43

 

SOURCE Venus225 Supplements


These press releases may also interest you

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...

at 16:42
Grifols, S.A. ("Grifols") (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today announces the filing of its Annual Report on Form 20-F for the fiscal year ended December 31,...

at 16:27
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Thursday, the FDA posted a safety communication to inform the public and healthcare providers that the agency has required and...

at 16:19
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....



News published on and distributed by: